Back to News
Market Impact: 0.2
Arrowhead Pharmaceuticals, Inc. Refinances Senior Secured Term Loans with $400.0 million Credit Facility
Source: Nasdaq
Credit & Bond MarketsCompany Fundamentals
On November 2, 2026, Arrowhead Pharmaceuticals and its subsidiary Arrowhead Madison Inc. entered into an amended and restated financing agreement with lenders and Sixth Street Lending Partners to refinance senior secured term loans. The provided article text ends before the new financing terms are complete, so the loan amount, pricing and other potential implications are not specified.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT
- Snap shares fall over 10% on third-quarter earnings miss
- Democrats may go after data centers. That's not a reason to dump all your AI stocks
- Host Hotels & Resorts CEO on 3Q Quarterly Results